Lake Street Downgrades Augmedix to Hold
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Brooks O'Neil has downgraded Augmedix (NASDAQ:AUGX) from Buy to Hold.
July 22, 2024 | 4:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Lake Street analyst Brooks O'Neil has downgraded Augmedix (NASDAQ:AUGX) from Buy to Hold, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold by a reputable analyst suggests a less favorable view on the stock's short-term performance, likely leading to a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100